Bone Structure and Turnover in Postmenopausal Women With Long-Standing Type 1 Diabetes.
BONE FORMATION
BONE HISTOMORPHOMETRY
BONE STRUCTURE
BONE TURNOVER
TYPE 1 DIABETES
Journal
JBMR plus
ISSN: 2473-4039
Titre abrégé: JBMR Plus
Pays: England
ID NLM: 101707013
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
28
06
2023
revised:
12
09
2023
accepted:
25
09
2023
medline:
29
11
2023
pubmed:
29
11
2023
entrez:
29
11
2023
Statut:
epublish
Résumé
Compromised bone structural and mechanical properties are implicated in the increased fracture risk in type 1 diabetes (T1D). We investigated bone structure and turnover by histomorphometry in postmenopausal women with T1D and controls without diabetes using tetracycline double-labeled transiliac bone biopsy. After in vivo tetracycline double labeling, postmenopausal women with T1D of at least 10 years and without diabetes underwent transiliac bone biopsy. An expert blinded to the study group performed histomorphometry. Static and dynamic histomorphometry measurements were performed and compared between the two groups. The analysis included 9 postmenopausal women with T1D (mean age 58.4 ± 7.1 years with 37.9 ± 10.9 years of diabetes and HbA1c 7.1% ± 0.4%) and 7 postmenopausal women without diabetes (mean age 60.9 ± 3.3 years and HbA1c 5.4% ± 0.2%). There were no significant differences in serum PTH (38.6 ± 8.1 versus 51.9 ± 23.9 pg/mL), CTX (0.4 ± 0.2 versus 0.51 ± 0.34 ng/mL), or P1NP (64.5 ± 26.2 versus 87.3 ± 45.3 ng/mL). Serum 25-hydroxyvitamin D levels were higher in T1D than in controls (53.1 ± 20.8 versus 30.9 ± 8.2 ng/mL,
Identifiants
pubmed: 38025041
doi: 10.1002/jbm4.10831
pii: JBM410831
pmc: PMC10652172
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e10831Informations de copyright
© 2023 The Authors. JBMR Plus published by Wiley Periodicals LLC. on behalf of American Society for Bone and Mineral Research.
Références
J Bone Miner Res. 1997 Apr;12(4):498-508
pubmed: 9101361
Curr Osteoporos Rep. 2020 Aug;18(4):371-377
pubmed: 32504189
Endocrinology. 2008 Apr;149(4):1697-704
pubmed: 18162513
Eur J Endocrinol. 2017 Mar;176(3):R137-R157
pubmed: 28049653
Diabetes. 1995 Jul;44(7):775-82
pubmed: 7789645
Curr Osteoporos Rep. 2022 Dec;20(6):398-409
pubmed: 36190648
Diabetes Technol Ther. 2023 May;25(5):324-328
pubmed: 36790875
Calcif Tissue Int. 2017 Mar;100(3):235-243
pubmed: 28013363
Bone. 1999 Oct;25(4):389-95
pubmed: 10511104
Bone. 2007 May;40(5):1408-14
pubmed: 17251074
Diabetes. 2003 Nov;52(11):2833-9
pubmed: 14578303
J Clin Endocrinol Metab. 2019 Oct 1;104(10):4356-4364
pubmed: 31127824
J Bone Miner Res. 2016 Jan;31(1):190-5
pubmed: 26234180
Connect Tissue Res. 2016 Jul;57(4):277-89
pubmed: 27028715
J Bone Miner Res. 2013 Jan;28(1):2-17
pubmed: 23197339
Curr Opin Endocrinol Diabetes Obes. 2018 Aug;25(4):231-236
pubmed: 29794498
Bone. 2023 Jul;172:116753
pubmed: 37001628
Bone. 2016 Feb;83:149-155
pubmed: 26555635
Curr Osteoporos Rep. 2019 Dec;17(6):455-464
pubmed: 31713179
J Bone Miner Res. 2015 Dec;30(12):2188-99
pubmed: 26096924
Bone. 2019 Jun;123:260-264
pubmed: 30936041
Osteoporos Int. 2018 Mar;29(3):733-739
pubmed: 29290026
Diabet Med. 2015 Sep;32(9):1134-42
pubmed: 26096918
Curr Opin Endocrinol Diabetes Obes. 2021 Aug 1;28(4):360-370
pubmed: 34183538
J Orthop Surg Res. 2023 Mar 6;18(1):169
pubmed: 36872328
J Bone Miner Res. 2021 Jun;36(6):1048-1059
pubmed: 33825260
Osteoporos Int. 2017 Sep;28(9):2601-2610
pubmed: 28580510
J Clin Endocrinol Metab. 2020 Mar 1;105(3):
pubmed: 31676897
J Clin Endocrinol Metab. 2022 May 17;107(6):e2405-e2416
pubmed: 35188961
JBMR Plus. 2020 Aug 03;4(9):e10389
pubmed: 32995692
J Bone Miner Res. 1996 Dec;11(12):1967-75
pubmed: 8970900
Bone. 2012 Jan;50(1):91-6
pubmed: 22001578